Product NDC: | 65862-431 |
Proprietary Name: | Ranitidine |
Non Proprietary Name: | Ranitidine Hydrochloride |
Active Ingredient(s): | 15 mg/mL & nbsp; Ranitidine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-431 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090623 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100728 |
Package NDC: | 65862-431-74 |
Package Description: | 474 mL in 1 BOTTLE (65862-431-74) |
NDC Code | 65862-431-74 |
Proprietary Name | Ranitidine |
Package Description | 474 mL in 1 BOTTLE (65862-431-74) |
Product NDC | 65862-431 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ranitidine Hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20100728 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 15 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |